7.94
price up icon2.98%   0.23
after-market Dopo l'orario di chiusura: 7.94
loading
Precedente Chiudi:
$7.71
Aprire:
$7.62
Volume 24 ore:
325.80K
Relative Volume:
2.20
Capitalizzazione di mercato:
$297.02M
Reddito:
$128.45M
Utile/perdita netta:
$6.54M
Rapporto P/E:
158.80
EPS:
0.05
Flusso di cassa netto:
$-8.79M
1 W Prestazione:
+4.20%
1M Prestazione:
+7.15%
6M Prestazione:
+36.43%
1 anno Prestazione:
+88.15%
Intervallo 1D:
Value
$7.47
$8.69
Intervallo di 1 settimana:
Value
$7.365
$8.69
Portata 52W:
Value
$4.33
$8.85

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Name
Nome
Lifecore Biomedical Inc
Name
Telefono
(952) 368-4300
Name
Indirizzo
3515 LYMAN BOULEVARD, CHASKA
Name
Dipendente
406
Name
Cinguettio
Name
Prossima data di guadagno
2025-04-03
Name
Ultimi documenti SEC
Name
LFCR's Discussions on Twitter

Confronta LFCR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
LFCR
Lifecore Biomedical Inc
7.94 279.06M 128.45M 6.54M -8.79M 0.05
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
153.20 67.75B 9.39B 2.62B 2.22B 5.81
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.29 47.88B 29.96B 957.25M 4.77B 0.304
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.84 43.70B 14.26B 1.98B 2.47B 0.4347
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
18.48 21.51B 16.70B -157.13M 1.19B -0.155
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
380.47 18.31B 2.99B 1.21B 1.13B 25.06

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-21 Iniziato William Blair Outperform
2024-09-05 Iniziato Craig Hallum Buy
2024-08-28 Downgrade Barrington Research Outperform → Mkt Perform
2023-03-20 Downgrade Stephens Overweight → Equal-Weight

Lifecore Biomedical Inc Borsa (LFCR) Ultime notizie

pulisher
Sep 03, 2025

What’s next for Lifecore Biomedical Inc. stock price2025 Short Interest & Accurate Buy Signal Notifications - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Detecting price anomalies in Lifecore Biomedical Inc. with AI2025 Geopolitical Influence & Fast Entry Momentum Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to monitor Lifecore Biomedical Inc. with trend dashboardsStop Loss & Long-Term Safe Investment Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Full technical analysis of Lifecore Biomedical Inc. stockJuly 2025 Momentum & Short-Term High Return Strategies - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Exit strategy if you’re trapped in Lifecore Biomedical Inc. - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Lifecore Biomedical Inc. stock recover after recent dropQuarterly Trade Report & AI Driven Stock Movement Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Should you wait for a breakout in Lifecore Biomedical Inc.Stop Loss & Growth Focused Stock Pick Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Lifecore Biomedical Inc. stock entering bullish territory2025 Major Catalysts & High Yield Equity Trading Tips - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Lifecore Biomedical Inc. stock chart pattern explainedWeekly Volume Report & Community Shared Stock Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Lifecore Biomedical to Participate in Upcoming Investor Conferences - GlobeNewswire

Sep 02, 2025
pulisher
Sep 02, 2025

What’s the beta of Lifecore Biomedical Inc. stockJuly 2025 Chart Watch & Real-Time Volume Triggers - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Lifecore Biomedical to Participate in Investor Conferences - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

CDMO Leader Lifecore Biomedical Announces Triple Conference Schedule Including Morgan Stanley Healthcare - Stock Titan

Sep 02, 2025
pulisher
Sep 02, 2025

Does Lifecore Biomedical Inc. stock benefit from AI growthJuly 2025 Update & Safe Capital Growth Stock Tips - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Published on: 2025-09-02 13:35:37 - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Detecting support and resistance levels for Lifecore Biomedical Inc.Dollar Strength & AI Powered Market Entry Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What to do if you’re stuck in Lifecore Biomedical Inc.Analyst Upgrade & Proven Capital Preservation Methods - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Sep 02, 2025
pulisher
Sep 02, 2025

What are the risks of holding Lifecore Biomedical Inc.July 2025 Weekly Recap & Entry Point Confirmation Signals - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Can a trend reversal in Lifecore Biomedical Inc. lead to recoveryMarket Performance Summary & Reliable Volume Spike Trade Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What are the future prospects of Lifecore Biomedical Inc.2025 Trading Recap & Stepwise Trade Signal Implementation - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Will Lifecore Biomedical Inc. benefit from seasonalityPortfolio Return Report & Trade Opportunity Analysis - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

Is Lifecore Biomedical Inc. forming bullish engulfing patternsSell Signal & Consistent Profit Trade Alerts - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Using RSI to spot recovery in Lifecore Biomedical Inc.July 2025 Institutional & Long-Term Investment Growth Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Lifecore Biomedical’s (NASDAQ:LFCR) Undervaluation and Growth Potential: A Case for Strategic Investment - AInvest

Sep 01, 2025
pulisher
Sep 01, 2025

Using data models to predict Lifecore Biomedical Inc. stock movement2025 Performance Recap & Risk Managed Trade Strategies - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Lifecore Biomedical, Inc.'s (NASDAQ:LFCR) Intrinsic Value Is Potentially 44% Above Its Share Price - Yahoo Finance

Sep 01, 2025
pulisher
Sep 01, 2025

Applying sector rotation models to Lifecore Biomedical Inc.Market Movers & Safe Entry Point Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

How hedge fund analytics apply to Lifecore Biomedical Inc. stockEntry Point & Stepwise Trade Signal Implementation - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Is Lifecore Biomedical Inc. forming a bullish divergenceWeekly Market Report & Stepwise Swing Trade Plans - kpenews.com

Aug 31, 2025
pulisher
Aug 31, 2025

Predicting Lifecore Biomedical Inc. trend using moving averages2025 Performance Recap & Technical Pattern Based Signals - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Relative strength of Lifecore Biomedical Inc. in sector analysisJuly 2025 Update & AI Powered Market Entry Strategies - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - ACCESS Newswire

Aug 31, 2025
pulisher
Aug 31, 2025

Automated trading signals detected on Lifecore Biomedical Inc.Trade Analysis Summary & Comprehensive Market Scan Insights - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Ranking Lifecore Biomedical Inc. among high performing stocks via toolsMarket Weekly Review & Weekly Top Stock Performers List - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

How sentiment analysis helps forecast Lifecore Biomedical Inc.Weekly Trade Analysis & Consistent Profit Trade Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Is Lifecore Biomedical Inc. stock ready for a breakoutJuly 2025 Action & Risk Controlled Swing Trade Alerts - Newser

Aug 30, 2025

Lifecore Biomedical Inc Azioni (LFCR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Lifecore Biomedical Inc Azioni (LFCR) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
English Aron R.
10% Owner
May 28 '25
Sale
7.12
150,419
1,071,555
264,180
English Aron R.
10% Owner
May 23 '25
Sale
6.75
96,137
649,386
1,554,103
English Aron R.
10% Owner
May 13 '25
Sale
7.00
12,334
86,353
1,650,240
English Aron R.
10% Owner
May 12 '25
Sale
7.03
45,698
321,426
1,662,574
English Aron R.
10% Owner
May 08 '25
Sale
7.00
5,098
35,693
1,708,972
English Aron R.
10% Owner
May 09 '25
Sale
7.00
700
4,900
1,708,272
English Aron R.
10% Owner
May 05 '25
Sale
7.08
24,543
173,831
1,730,618
English Aron R.
10% Owner
May 07 '25
Sale
7.01
15,847
111,099
1,714,070
English Aron R.
10% Owner
May 06 '25
Sale
7.05
701
4,940
1,729,917
Josephs Paul
Chief Executive Officer
Jan 08 '25
Buy
5.74
17,000
97,580
559,717
$28.92
price down icon 3.60%
$17.47
price up icon 0.69%
drug_manufacturers_specialty_generic RDY
$14.15
price down icon 0.28%
$10.33
price down icon 2.09%
$140.40
price up icon 3.15%
$380.47
price down icon 2.80%
Capitalizzazione:     |  Volume (24 ore):